The global molecular diagnostics market is anticipated to increase as a result of increasing product releases by industry players. For example, on May 17, 2022, QIAGEN N.V., a provider of sample and assay technologies for molecular diagnostics, applied testing, and academic and pharmaceutical research, announced the release of the therascreen EGFR plus RGQ PCR Kit, a new in-vitro diagnostic test for sensitive epidermal growth factor receptor (EGFR) mutation analysis that can identify all EGFR mutations, including activating and resistance mutations. Improved limits of detection, quicker turnaround times, automated sample extraction choices, and automated results interpretation are all features of the real-time quantitative polymerase chain reaction (qPCR) test, which is a development of the well-established therascreen EGFR RGQ PCR Kit.
Global Molecular Diagnostics Market is estimated to be valued at US$ 14,772.2 million in 2022 and is expected to exhibit a CAGR of 11.6% during the forecast period (2022-2030).
Leading Companies in the Molecular Diagnostics Industry:
1. Hologic,Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts and is operational in more than 100 countries.
2. Grifols, S.A.
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. It has headquarters situated in Barcelona, Spain has a presence in more than 30 countries.
3. Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
4. Qiagen N.V.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. In January, 2023 QIAGEN announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for widescale use 18 months after being made available for research.
5. Cepheid
Cepheid is a leading molecular diagnostics company and was founded in 1996. The company has headquarters situated in Sunnyvale, California.
6. F. Hoffmann-La Roche Ltd.
Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.
7. Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. In January, 2023 BD (Becton, Dickinson and Company) introduced a new, robotic track system for the BD Kiestra™ microbiology laboratory solution that automates lab specimen processing, which may help to reduce manual labor and wait time for results.
8. Siemens Healthineers
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. In November, 2022 Siemens Healthineers and Atrium Health, a leading nonprofit health provider known for its top-ranked pediatric, cancer and heart care programs, have announced a multi-year Value Partnership1 agreement.
*Definition- Molecular diagnostics tests done for finding disturbance in the specific sequences in Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA), which may be linked with disease.
